Dr. William Abraham, MD
NPI: 1093755944
Total Payments
$1.1M
2024 Payments
$153,751
Companies
19
Transactions
214
Medicare Patients
332
Medicare Billing
$18,896
Payment Breakdown by Category
Consulting$888,937 (78.3%)
Other$173,489 (15.3%)
Research$37,320 (3.3%)
Travel$31,674 (2.8%)
Food & Beverage$4,260 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $888,937 | 86 | 78.3% |
| Honoraria | $100,800 | 14 | 8.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,289 | 19 | 4.2% |
| Unspecified | $37,320 | 10 | 3.3% |
| Travel and Lodging | $31,674 | 37 | 2.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $21,900 | 3 | 1.9% |
| Food and Beverage | $4,260 | 44 | 0.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,500 | 1 | 0.3% |
Payments by Type
General
$1.1M
204 transactions
Research
$37,320
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Respicardia, Inc. | $273,555 | 12 | $0 (2020) |
| Sensible Medical Innovations Ltd | $267,000 | 6 | $0 (2024) |
| ZOLL Respicardia, Inc. | $206,800 | 19 | $0 (2024) |
| SCPHARMACEUTICALS INC. | $90,000 | 8 | $0 (2024) |
| Abbott Laboratories | $71,789 | 55 | $0 (2024) |
| CVRx, Inc. | $65,334 | 25 | $0 (2024) |
| Edwards Lifesciences Corporation | $30,287 | 39 | $0 (2022) |
| Boehringer Ingelheim France S.A.S. | $29,906 | 2 | $0 (2020) |
| Impulse Dynamics (USA) Inc. | $28,000 | 12 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $26,174 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153,751 | 22 | ZOLL Respicardia, Inc. ($51,850) |
| 2023 | $143,814 | 21 | ZOLL Respicardia, Inc. ($45,100) |
| 2022 | $109,988 | 8 | Sensible Medical Innovations Ltd ($54,000) |
| 2021 | $72,439 | 8 | ZOLL Respicardia, Inc. ($60,000) |
| 2020 | $101,583 | 11 | Respicardia, Inc. ($55,238) |
| 2019 | $152,406 | 13 | Sensible Medical Innovations Ltd ($72,000) |
| 2018 | $217,866 | 67 | Respicardia, Inc. ($65,548) |
| 2017 | $183,833 | 64 | Respicardia, Inc. ($91,034) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Sensible Medical Innovations Ltd | ReDS system (Device) | Consulting Fee | Cash or cash equivalent | $36,000.00 | General |
| Category: Heart failure | ||||||
| 12/10/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Honoraria | Cash or cash equivalent | $11,250.00 | General |
| Category: Cardiology | ||||||
| 12/01/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Honoraria | Cash or cash equivalent | $11,250.00 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| Category: Respiratory | ||||||
| 07/26/2024 | CVRx, Inc. | Barostim Neo System (Device) | — | Cash or cash equivalent | $2,500.00 | Research |
| Category: Heart Failure and Hypertension | ||||||
| 07/01/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $15,000.00 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Honoraria | Cash or cash equivalent | $11,250.00 | General |
| Category: Cardiology | ||||||
| 06/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $120.51 | General |
| Category: Heart Failure | ||||||
| 05/28/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $116.80 | General |
| Category: Heart Failure | ||||||
| 04/10/2024 | CVRx, Inc. | Barostim Neo System (Device) | — | Cash or cash equivalent | $8,000.00 | Research |
| Category: Heart Failure and Hypertension | ||||||
| 03/27/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| Category: Respiratory | ||||||
| 03/22/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Honoraria | Cash or cash equivalent | $11,250.00 | General |
| Category: Cardiology | ||||||
| 03/01/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| Category: Respiratory | ||||||
| 02/09/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $28.39 | General |
| Category: Cardiology | ||||||
| 02/01/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $9,100.00 | General |
| Category: Respiratory | ||||||
| 01/18/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: Cardiovascular Device | ||||||
| 01/10/2024 | CVRx, Inc. | Barostim Neo System (Device) | — | Cash or cash equivalent | $8,500.00 | Research |
| Category: Heart Failure and Hypertension | ||||||
| 01/04/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $135.24 | General |
| Category: Heart Failure | ||||||
| 12/26/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Honoraria | Cash or cash equivalent | $11,250.00 | General |
| Category: Cardiology | ||||||
| 10/25/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Respiratory | ||||||
| 10/24/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| Category: Heart Failure | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CEASE-MR | Abbott Laboratories | $1,788 | 1 |
| Aquarius | Medtronic Vascular, Inc. | $450.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 63 | 85 | $12,205 | $3,822 |
| 2022 | 2 | 78 | 96 | $11,760 | $4,042 |
| 2021 | 3 | 95 | 129 | $16,699 | $6,163 |
| 2020 | 3 | 96 | 122 | $17,338 | $4,869 |
Total Patients
332
Total Services
432
Medicare Billing
$18,896
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 63 | 85 | $12,205 | $3,822 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 62 | 79 | $10,400 | $3,601 | 34.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 16 | 17 | $1,360 | $440.37 | 32.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 55 | 74 | $9,609 | $3,609 | 37.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 28 | $4,954 | $1,809 | 36.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 23 | 27 | $2,136 | $745.22 | 34.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 57 | 71 | $9,230 | $2,698 | 29.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 28 | 40 | $7,228 | $1,941 | 26.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 11 | 11 | $880.00 | $231.11 | 26.3% |
About Dr. William Abraham, MD
Dr. William Abraham, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093755944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Abraham, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $153,751 received in 2024. These payments were reported across 214 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($888,937).
As a Medicare-enrolled provider, Abraham has provided services to 332 Medicare beneficiaries, totaling 432 services with total Medicare billing of $18,896. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology
- Location Columbus, OH
- Active Since 06/08/2006
- Last Updated 01/30/2026
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1093755944
Products in Payments
- remede System (Device) $480,355
- ReDS system (Device) $267,000
- FUROSCIX (Drug) $90,000
- Mitra Clip system (Device) $66,418
- Barostim Neo System (Device) $65,334
- JARDIANCE (Drug) $27,004
- Aquadex (Device) $18,000
- Optimizer Smart System (Device) $12,000
- EMPAGLIFLOZIN (Drug) $9,892
- OPTIMIZER SMART SYSTEM (Device) $6,000
- Optimizer (Device) $6,000
- OPTIMIZER (Device) $4,000
- ENTRESTO (Drug) $3,960
- CardiAMP (Biological) $3,008
- CardioMEMS HF System (Device) $2,321
- Tendyne Mitral Valve System (Device) $1,788
- Product in Development (Device) $800.00
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $550.00
- CARDIOMEMS (Device) $516.07
- EP Recording Systems (Device) $115.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Columbus
Katherine Dodd, D.o, D.O
Advanced Heart Failure and Transplant Cardiology — Payments: $3,530
Advanced Heart Failure and Transplant Cardiology $3,530
Rodolfo Jose Denadai Benatti, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $1,700
Advanced Heart Failure and Transplant Cardiology $1,700